EP1746993A4 - Controlled release metformin compositions - Google Patents

Controlled release metformin compositions

Info

Publication number: EP1746993A4
Authority: EP; European Patent Office
Prior art keywords: controlled release; release metformin; metformin compositions; compositions; controlled
Prior art date: 2004-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05742346A

Other languages

German (de)

French (fr)

Other versions

EP1746993A1 (en

Inventor

Xiu-Xiu Cheng

Edward I Cullen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Andrx Laboratories LLC

Original Assignee

Andrx Laboratories LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-29

Filing date

2005-04-29

Publication date

2007-08-29

2005-04-29 Application filed by Andrx Laboratories LLC filed Critical Andrx Laboratories LLC

2007-01-31 Publication of EP1746993A1 publication Critical patent/EP1746993A1/en

2007-08-29 Publication of EP1746993A4 publication Critical patent/EP1746993A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

EP05742346A 2004-04-29 2005-04-29 Controlled release metformin compositions Withdrawn EP1746993A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US56649104P	2004-04-29	2004-04-29
PCT/US2005/014826 WO2005107750A1 (en)	2004-04-29	2005-04-29	Controlled release metformin compositions

Publications (2)

Publication Number	Publication Date
EP1746993A1 EP1746993A1 (en)	2007-01-31
EP1746993A4 true EP1746993A4 (en)	2007-08-29

Family

ID=35320027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05742346A Withdrawn EP1746993A4 (en)	2004-04-29	2005-04-29	Controlled release metformin compositions

Country Status (4)

Country	Link
EP (1)	EP1746993A4 (en)
JP (1)	JP2007535557A (en)
CA (1)	CA2564750A1 (en)
WO (1)	WO2005107750A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002036100A1 (en) *	2000-11-03	2002-05-10	Andrx Corporation	Controlled release metformin compositions
US6790459B1 (en) *	2000-11-03	2004-09-14	Andrx Labs, Llc	Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) *	2000-11-03	2005-03-15	Andrx Labs, Llc	Controlled release metformin compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6559188B1 (en) *	1999-09-17	2003-05-06	Novartis Ag	Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US6586438B2 (en) *	1999-11-03	2003-07-01	Bristol-Myers Squibb Co.	Antidiabetic formulation and method
WO2001082916A2 (en) *	2000-05-03	2001-11-08	Tularik Inc.	Combination therapeutic compositions and methods of use

2005
- 2005-04-29 JP JP2007511018A patent/JP2007535557A/en active Pending
- 2005-04-29 EP EP05742346A patent/EP1746993A4/en not_active Withdrawn
- 2005-04-29 WO PCT/US2005/014826 patent/WO2005107750A1/en not_active Application Discontinuation
- 2005-04-29 CA CA002564750A patent/CA2564750A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002036100A1 (en) *	2000-11-03	2002-05-10	Andrx Corporation	Controlled release metformin compositions
US6790459B1 (en) *	2000-11-03	2004-09-14	Andrx Labs, Llc	Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) *	2000-11-03	2005-03-15	Andrx Labs, Llc	Controlled release metformin compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005107750A1 *

Also Published As

Publication number	Publication date
WO2005107750A1 (en)	2005-11-17
EP1746993A1 (en)	2007-01-31
CA2564750A1 (en)	2005-11-17
JP2007535557A (en)	2007-12-06

Legal Events

Date	Code	Title	Description
2006-12-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-01-31	17P	Request for examination filed	Effective date: 20061026
2007-01-31	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
2007-08-08	DAX	Request for extension of the european patent (deleted)
2007-08-29	A4	Supplementary search report drawn up and despatched	Effective date: 20070727
2007-08-29	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/36 20060101ALI20070723BHEP Ipc: A61P 5/48 20060101ALI20070723BHEP Ipc: A61K 31/155 20060101AFI20070723BHEP
2011-01-19	17Q	First examination report despatched	Effective date: 20101221
2011-09-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-10-26	18D	Application deemed to be withdrawn	Effective date: 20110503

Publication	Publication Date	Title
GB0406819D0 (en)	2004-04-28	Controlled release compositions
EP1656115A4 (en)	2009-07-08	Controlled release compositions
EP1718714A4 (en)	2009-12-16	Tracer-containing compositions
GB0409375D0 (en)	2004-06-02	Phytoactive composition
ZA200904425B (en)	2010-11-24	Nemathical compositions
EP1726304A4 (en)	2010-04-28	Solifenacin-containing composition
EP1607088A4 (en)	2009-12-09	Controlled release composition
GB0405406D0 (en)	2004-04-21	Anti-vaginitis compositions
PL1827105T3 (en)	2009-08-31	Herbicidal composition
GB0425795D0 (en)	2004-12-22	Composition
GB0410038D0 (en)	2004-06-09	Composition
IL177328A0 (en)	2006-12-10	Controlled release formulations
GB0414803D0 (en)	2004-08-04	Composition
GB0416861D0 (en)	2004-09-01	Composition
GB0415981D0 (en)	2004-08-18	Composition
GB0417357D0 (en)	2004-09-08	Composition
ZA200701197B (en)	2008-09-25	Compositions
GB0410140D0 (en)	2004-06-09	Compositions
EP1746993A4 (en)	2007-08-29	Controlled release metformin compositions
GB0420627D0 (en)	2004-10-20	Monoglyceride-containing compositions
GB0417388D0 (en)	2004-09-08	Composition
GB0426717D0 (en)	2005-01-12	Herbicidal composition
GB0409598D0 (en)	2004-06-02	Composition
GB0419489D0 (en)	2004-10-06	Weathered-effect composition
GB0322044D0 (en)	2003-10-22	Controlled release compositions